Global Consensus Position Statement on the Use of Testosterone Therapy for Women
Categories: early menopause, hypoactive sexual desire dysfunction HSDD, Medical Professional News, low libido in women, testosterone for women, testosterone, menopause, hysterectomy
Posted: November 26, 2019
The Global Consensus Position Statement on the Use of Testosterone Therapy for Women was simultaneously published on the 2nd September 2019 in Maturitas, Journal of Clinical Endocrinolgy and Metabolism (JCEM), Climacteric and the Journal of Sexual Medicine in 14 languages.
Read the full paper at https://www.imsociety.org/position_papers_and_consensus_statements.php
Latest News
Reasons for PBAC denial of women’s testosterone therapy released: “inequitable” and “scientifically flawed”
MEDIA RELEASE – Embargo 12.00 am, 27 March 2026 Reasons for PBAC denial of women’s testosterone therapy released: “inequitable” and “scientifically flawed” Last Friday,… Continue Reading →
AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT
MEDIA RELEASE – Wed 11 February 2026 AUSTRALIAN MINNOW, LAWLEY PHARMACEUTICALS, TAKES PBAC TO FEDERAL COURT A small Perth-based pharmaceutical company is stepping up… Continue Reading →
